Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 02, 2023

Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio and Other Inflammatory Biomarkers in Patients With Primary Retroperitoneal Sarcomas

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Preoperative Neutrophil-To-Lymphocyte Ratio And A New Inflammatory Biomarkers Prognostic Index For Primary Retroperitoneal Sarcomas
Clin. Cancer Res 2022 Dec 07;[EPub Ahead of Print], M Fiore, S Ljevar, S Pasquali, D Morelli, D Callegaro, R Sanfilippo, M Barisella, C Sangalli, R Miceli, A Gronchi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading